Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting – verified May 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days